By Danielle Silva, VP of Business Development, LSN
Raising a financing round for a life science company is a long and challenging process. Unfortunately, some fundraising CEOs make it harder by making these common mistakes along the way. From overloading investors with too much information up front, to failing to do their homework on investors prior to reaching out, this presentation covers the most common errors we’ve seen out there on the road. An efficient and successful raise depends on avoiding these mistakes.
Next Phase Newsletter 
Leave a comment